FDA launches emergency program to speed COVID-19 drug development

The FDA has launched an emergency program with the goal of expediting the development of safe, effective drugs to treat COVID-19. 

The Coronavirus Treatment Acceleration Program is designed to bring new therapies to COVID-19 patients as quickly as possible while supporting research to determine whether those therapies are safe and effective. 

The agency said there are 10 "therapeutic agents" to treat COVID-19 that are in active trials and another 15 that are in planning stages. The FDA will update the numbers as they change. 

Read the full news release here

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars